Submission of Newspaper Advertisement of Audited Financial Results for the Quarter and year ended on 31st March, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Hemo Organic Ltd published its audited financial results for Q4 FY2026 and full year ended March 31, 2026 via newspaper advertisement on May 30, 2026 in Financial Express (English and Gujarati). Total income from operations for FY26 stood at Rs 28,218.69 lakhs, up from Rs 22,468.35 lakhs in FY25. Net profit after tax for the year was Rs 379.07 lakhs compared to Rs 332.06 lakhs in the previous year. EPS for FY26 was Rs 2.57 (annualised), up from Rs 2.25 in FY25. The company operates in a single reportable segment - TEXTILE. Results were reviewed by the audit committee and approved by the Board on May 29, 2026, and have been reviewed by statutory auditors. The quarter figures are balancing figures between audited annual figures and unaudited nine-month figures.
Positive financial performance with revenue and profit growth year-over-year. The filing confirms regulatory compliance with SEBI listing obligations. The stock (scrip code 524590, symbol HEMORGANIC) reported improved earnings per share.